Dermot Ryan
- Impact of therapy reviews in real-world asthmaBy David Price, John Haughney, Dermot Ryan, Iain Small, Kevin Gruffydd-Jones, Alison Chisholm, Stanley Musgrave, Naheem Munir, Federico Lavorini and Alberto PapiDavid PriceJohn Haughney1Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United KingdomDermot RyanIain Small5General Practice with Specialist Interest in Respiratory Medicine, Peterhead Health Centre Forrest Road, Peterhead, United KingdomKevin Gruffydd-JonesAlison Chisholm2Observational Research, Research in Real Life, Norwich, United KingdomStanley Musgrave2Observational Research, Research in Real Life, Norwich, United KingdomNaheem Munir2Observational Research, Research in Real Life, Norwich, United KingdomFederico Lavorini8Department Internal Medicine, Section Respiratory Medicine, University of Florence, Florence, ItalyAlberto Papi9Research Centre on Asthma and COPD, University of Ferrara, Ferrara, Italy
- COPD disease severity stratification obtained by electronic review of routinely collected primary care dataBy Dermot Ryan, Feargal Ryan, Catherine Blackaby, Rupert Jones and David PriceDermot RyanFeargal Ryan3Clinical Review Services, Optimum Patient Care, Norwich, United KingdomCatherine Blackaby4NHS Improvement: Lung, NHS, Leicester, United KingdomRupert Jones5GP, Armada Surgery, Plymouth, United Kingdom
- Comorbidities at time of COPD diagnosisBy David Price, David Halpin, Robert Winter, Susan Hill, Eric Bateman, Daryl Freeman, Dermot Ryan, Matthew Kearney, Kevin Holton, Annie Burden, Julie von Ziegenweidt, Laurence Mascarenhas, Alison Chisholm and Rupert JonesDavid PriceDavid Halpin3Royal Devon & Exeter Hospital, NHS Foundation Trust, Exeter, United KingdomRobert WinterSusan Hill4Respiratory Programme, Department of Health, London, United KingdomEric Bateman6Respiratory Medicine, University of Cape Town, Cape Town, South AfricaDaryl Freeman7General Practice with Specialist Interest in Respiratory Medicine, Sheringham Medical Practice, Norfolk, United KingdomDermot Ryan8General Practice with Specialist Interest in Respiratory Medicine, Woodbrook Medical Centre, Loughborough, United KingdomMatthew KearneyKevin Holton4Respiratory Programme, Department of Health, London, United KingdomAnnie Burden2Observational Research, Research in Real Life, Norwich, United KingdomJulie von Ziegenweidt2Observational Research, Research in Real Life, Norwich, United KingdomLaurence Mascarenhas2Observational Research, Research in Real Life, Norwich, United KingdomAlison Chisholm2Observational Research, Research in Real Life, Norwich, United KingdomRupert Jones10Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom
- Missed opportunities to diagnose COPDBy David Price, David Halpin, Robert Winter, Susan L. Hill, Eric Bateman, Daryl Freeman, Dermot Ryan, Matthew Kearney, Kevin Holton, Annie Burden, Julie von Ziegenweidt, Laurence Mascarenhas, Alison Chisholm and Rupert JonesDavid PriceDavid Halpin3Royal Devon & Exeter Hospital, NHS Foundation Trust, Exeter, United KingdomRobert WinterSusan L. Hill4Respiratory Programme, Department of Health, London, United KingdomEric Bateman6Respiratory Medicine, University of Cape Town, Cape Town, South AfricaDaryl Freeman7General Practice with Specialist Interest in Respiratory Medicine, Sheringham Medical Practice, Norfolk, United KingdomDermot Ryan8General Practice with Specialist Interest in Respiratory Medicine, Woodbrook Medical Centre, Loughborough, United KingdomMatthew KearneyKevin Holton4Respiratory Programme, Department of Health, London, United KingdomAnnie Burden2Observational Research, Research in Real Life, Norwich, United KingdomJulie von Ziegenweidt2Observational Research, Research in Real Life, Norwich, United KingdomLaurence Mascarenhas2Observational Research, Research in Real Life, Norwich, United KingdomAlison Chisholm2Observational Research, Research in Real Life, Norwich, United KingdomRupert Jones10Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom
- Blood eosinophilia and the number of exacerbations in COPD patientsBy David Price, Anna Rigazio, Dirkje Postma, Alberto Papi, Bruselle Guy, Alvar Agusti, Antonio Anzueto, Claus Vogelmeier, Dermot Ryan, Daryl Freeman, Mike Thomas, Ian Pavord, Mona Bafadhel, Nicolas Roche, Rupert Jones, Ted Popov, Emilio Pizzichini, Alison Chisholm and Marjan KerkhofDavid Price1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom2Center of Academic Primary Care, University of Aberdeen, Aberdeen, United KingdomAnna Rigazio3Research in Real Life Ltd, (RiRL), Cambridge, United KingdomDirkje Postma1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom4Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsAlberto Papi1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom5Respiratory Medicine and Research Center on Asthma and COPD, University of Ferrara, Ferrara, ItalyBruselle Guy1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom6Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumAlvar Agusti1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom7Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, SpainAntonio Anzueto1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom8Pulmonary/Critical Care, University of Texas Health Science Center, San Antonio,Claus Vogelmeier1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom9Pulmonary Division, Marburg University Hospital, Marburg, GermanyDermot Ryan1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom10General Practice, Woodbrook Medical Centre, Loughborough, United KingdomDaryl Freeman1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom11General Practice, Mundesley Medical Centre, Norfolk, United KingdomMike Thomas1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom12Department of Primary Care Research, University of Southampton, Southampton, United KingdomIan Pavord1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom13Department of Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomMona Bafadhel1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom13Department of Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomNicolas Roche1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom14Department of Respiratory and Intensive Care Medicine, Hôtel-Dieu Hospital by University Paris, Paris, FranceRupert Jones1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom15Peninsula School of Medicine and Dentistry, Plymouth University, Plymouth, United KingdomTed Popov1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom16Clinic of Allergy & Asthma, Medical University Sofia, Sofia, BulgariaEmilio Pizzichini1Respiratory Effectiveness Group, (REG), Cambridge, United Kingdom17Department of Pulmonology, University of Santa Catarin, Florianópolis, BrazilAlison Chisholm1Respiratory Effectiveness Group, (REG), Cambridge, United KingdomMarjan Kerkhof3Research in Real Life Ltd, (RiRL), Cambridge, United Kingdom
- Prevalence of chronic kidney disease (CKD) in the UK COPD populationBy David Price, Emily Davis, Anna Gilchrist, Daniel West, Marjan Kerklof and Dermot RyanDavid Price1Respiratory, Research in Real Life, Cambridge, United Kingdom2Division of Applied Health Sciences, Aberdeen University, Aberdeen, United KingdomEmily Davis1Respiratory, Research in Real Life, Cambridge, United KingdomAnna Gilchrist1Respiratory, Research in Real Life, Cambridge, United KingdomDaniel West1Respiratory, Research in Real Life, Cambridge, United KingdomMarjan Kerklof1Respiratory, Research in Real Life, Cambridge, United KingdomDermot Ryan3The University of Edinburgh, Edinburgh, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.